Your browser doesn't support javascript.
loading
Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas.
Kitadate, Akihiro; Ikeda, Sho; Abe, Fumito; Takahashi, Naoto; Shimizu, Norio; Matsue, Kosei; Tagawa, Hiroyuki.
Affiliation
  • Kitadate A; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine.
  • Ikeda S; Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan.
  • Abe F; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine.
  • Takahashi N; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine.
  • Shimizu N; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine.
  • Matsue K; Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo.
  • Tagawa H; Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan.
Haematologica ; 103(1): 126-135, 2018 01.
Article in En | MEDLINE | ID: mdl-29025909
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Lymphoma, T-Cell / Drug Resistance, Neoplasm / Receptors, CCR4 / Histone Deacetylase Inhibitors Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Lymphoma, T-Cell / Drug Resistance, Neoplasm / Receptors, CCR4 / Histone Deacetylase Inhibitors Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article